About the Company
Robert Half Inc. is an international human resource consulting firm founded in 1948, based in Menlo Park and San Ramon, California. It is among the world's largest accounting and finance staffing firms, with over 345 locations worldwide. Through its Accountemps, Finance & Accounting, and Management Resources divisions, the company provides staff in the fields of accounting and finance. Other divisions include Robert Half Technology, providing software, application, IT infrastructure and operations professionals; Office Team, which specializes in administrative and customer service staffing; The Creative Group, which focuses on design, artistic, and creative talent; and Robert Half Legal, which provides staffing for legal professionals. In 2002, Robert Half founded a subsidiary, Protiviti Inc., a subsidiary, to provide internal audit, financial, operations, technology, governance, and risk consulting services.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Sana Biotechnology, Inc.
Sana Biotechnology, Inc. Sued for Securities Law Violations - Investors ...
Sana Biotechnology, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 20, 2025 to Discuss Your Rights - SANA Provided by PR Newswire May 12, 2025 2:45am ...
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana ...
PR Newswire Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA ...
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public ...
The Gross Law Firm Reminds Sana Biotechnology, Inc. Investors of the ...
NEW YORK, April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA).
Sana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program Prospects
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the penny stocks that will skyrocket. On June 24, analysts at Citizens JMP reiterated a ‘Market Outperform’ rating on the stock and a $5 price target.
Shareholders that lost money on Sana Biotechnology, Inc. (SANA ... - WWLP
If you suffered a loss in Sana Biotechnology, Inc. during the relevant time frame, you have until May 20, 2025 to request that the Court appoint you as lead plaintiff.
Sana Biotechnology Announces Pricing of Public Offering
Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten public offering ...
Sana Biotechnology to Present at June 2025 Investor Conferences
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast ...
Sana Biotechnology, Inc. (SANA) Secures an Overweight Rating from ...
Sana Biotechnology, Inc. (NASDAQ:SANA) is a Washington-based biotechnology company that uses engineered cells as medicines across the United States. The core offerings of the company include UP421 ...
Commit To Purchase Sana Biotechnology At $2.50, Earn 28% Using ... - Nasdaq
So unless Sana Biotechnology Inc sees its shares fall 45.4% and the contract is exercised (resulting in a cost basis of $1.80 per share before broker commissions, subtracting the 70 cents from $2. ...
Sana Biotech's UP421 Shows Durable Insulin Secretion Without ...
(RTTNews) - Sana Biotechnology, Inc. (SANA) announced positive six-month follow-up results Monday from a first-in-human study using UP421—engineered pancreatic islet cells modified with its ...
Sana Biotechnology, Inc. Sued for Securities Law Violations - Investors ...
NEW YORK, May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA). Shareholders who purchased shares of SANA during ...
Similar Companies
Loading the latest forecasts...